Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial fibrillation, anticoagulation, and stroke

J Morley1, R Marinchak, S J Rials

  • 1Division of Cardiovascular Diseases, Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania 19096, USA.

The American Journal of Cardiology
|January 25, 1996
PubMed
Summary

Atrial fibrillation increases stroke risk, especially with hypertension, age, prior TIA, or diabetes. Warfarin therapy significantly reduces stroke risk by 64% in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase transitions in the classical simulability of open quantum systems.

Scientific reports·2023
Same author

Editorial: Loneliness in Old Age: An unaddressed Health Problem.

The journal of nutrition, health & aging·2020
Same author

Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Designing Drug Trials for Frailty: ICFSR Task Force 2018.

The Journal of frailty & aging·2018
Same author

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2018
Same author

Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

The journal of nutrition, health & aging·2013

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Trials

Background:

  • Atrial fibrillation (AF) is linked to rheumatic valvular disease and embolic stroke.
  • Identifying high-risk AF patients for stroke prevention is crucial.

Purpose of the Study:

  • To assess clinical trial data on stroke risk in atrial fibrillation patients.
  • To evaluate the efficacy of anticoagulation therapy, specifically warfarin, in reducing stroke risk.

Main Methods:

  • Analysis of 6 major clinical trials (AFASAK, BAATAF, SPINAF, SPAF, CAFA, EAFTA).
  • Multivariate analysis to identify independent clinical risk factors for stroke in AF patients.
  • Meta-analysis of warfarin therapy versus placebo.

Main Results:

Related Experiment Videos

  • Hypertension, increasing age, previous transient ischemic attack (TIA), and diabetes mellitus are key stroke risk factors in AF.
  • Patients with these risk factors face a 4% annual stroke risk without anticoagulation.
  • Warfarin therapy demonstrated a 64% risk reduction for stroke compared to placebo.
  • Higher risk of hemorrhagic complications with warfarin in patients over 75.

Conclusions:

  • Warfarin therapy is effective in reducing stroke risk for AF patients with identified risk factors.
  • Risk stratification using clinical features aids in targeted anticoagulation decisions.
  • Caution is advised for warfarin use in elderly AF patients due to bleeding risks.